FDA Inspection
Merck Sharp & Dohme LLCMerck Sharp & Dohme LLC – FDA Inspection, Sep 12, 2025
Record Details
This FDA Inspection record concerns Merck Sharp & Dohme LLC, with an inspection on September 12, 2025, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · ce489b6d-e1bd-4922-86f5-8ce52d78eb3f
Inspection Facts
- Inspection number
- 1281516
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.113(a)Procedures for non-sterile drug products
- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.182Written records kept in individual logs
- 21 CFR 211.192No written record of investigation
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.84(e)Rejecting When Specifications Not Met
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Merck Sharp & Dohme LLC
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2026 | Not classified | Atlanta District Office | |
| November 16, 2023 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| April 5, 2019 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| May 3, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 21, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Merck Sharp & Dohme LLC
- FDA Inspection 1307924 - 2026-02-13
- FDA Inspection 1225396 - 2023-11-16
- FDA Inspection 1089774 - 2019-04-05
- FDA Inspection 1056085 - 2018-05-03
- FDA Inspection 961626 - 2016-01-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.